Essential Partners’s ReposiTrak TRAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$737 Sell
88
-91
-51% -$767 ﹤0.01% 2286
2026
Q2
$1.61K Buy
179
+41
+30% +$375 ﹤0.01% 2061
2026
Q1
$1.05K Buy
138
+136
+6,800% +$1.31K ﹤0.01% 2229
2025
Q4
$25 Sell
2
-4
-67% -$57 ﹤0.01% 2702
2025
Q3
$89 Buy
6
+5
+500% +$87 ﹤0.01% 2505
2025
Q2
$20 Buy
+1
New +$21 ﹤0.01% 2221

Other funds holding TRAK

Essential Partners's TRAK Position: Q3 2026 in Review

Essential Partners reduced its ReposiTrak (TRAK) stake by 51% in Q3 2026, selling an estimated $767 and leaving 88 shares worth $737. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Essential Partners first reported a position in TRAK in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.61K in Q2 2026. 8 funds tracked by Wall St. Rank hold TRAK as of Q3 2026.

  • Essential Partners held 88 shares of ReposiTrak worth $737 as of Q3 2026.
  • Essential Partners sold 91 ReposiTrak shares in Q3 2026, an estimated $767.
  • ReposiTrak made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2286 holding.
  • Essential Partners first reported a position in ReposiTrak in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's ReposiTrak position peaked at $1.61K in Q2 2026.
  • 8 funds tracked by Wall St. Rank held ReposiTrak as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.